🇺🇸 FDA
Pipeline program

Mitomycin C

not required

Phase 2 small_molecule completed

Quick answer

Mitomycin C for Glaucoma is a Phase 2 program (small_molecule) at AEON Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
AEON Biopharma
Indication
Glaucoma
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials